Boston Scientific Corporation Gets Conditional OK for Liberte Stent

March 19, 2008 |

1 min read

CHICAGO (Reuters) - Medical device maker Boston Scientific Corp (BSX.N: Quote, Profile, Research) said on Tuesday its newest drug-eluting stent, the Taxus Liberte system, has received conditional approval from U.S. regulators.

FDA Approvals

MORE ON THIS TOPIC

Creative pattern made with a syringe on pastel pink background. Vaccine for Coronavirus infection. Pandemic concept.

COVID-19

FDA assembles vaccine experts to update COVID-19 formulation

May 27, 2026

·

2 min read

·

Tristan Manalac

Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review

Breast cancer

AstraZeneca’s breast cancer pill hit with review delay after negative adcomm vote

May 27, 2026

·

4 min read

·

Tristan Manalac

Isometric Office chair with vacancy sign isolated on blue background. Employment, vacancy and hiring job vector concept

Regulatory

Makary’s reforms will live on at FDA even as leadership turns over

May 27, 2026

·

2 min read

·

Tristan Manalac

Vaccine and syringe injection. Doctor hand with syringe. Vaccination of people for prevention, immunization and treatment from virus infection. Medicine, flu shot, test with needle. Vector

Adcomms

Moderna’s once-rebuffed mRNA flu shot to face scrutiny from FDA adcomm

May 22, 2026

·

2 min read

·

Tristan Manalac